Dossier table of contents and source map
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
PharmaRevix supports Module 1-5 compilation, baseline conversion, sequence management, validation, and submission-ready publishing across modern eCTD toolchains.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Index all source documents and submission requirements
Compile dossier modules and resolve gaps
Publish, validate, and correct technical issues
Package the final sequence for submission
The work is designed for real review: authority questions, partner due diligence, quality audits, and internal leadership updates.
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
PharmaRevix prepares CMC content, clinical and non-clinical overviews, risk assessments, and deficiency responses aligned to current ICH and regional expectations.
Explore servicePharmaRevix supports new applications, variations, renewals, annual reports, eCTD publishing, and MAH-related regulatory operations across key markets.
Explore servicePharmaRevix supports PI and DMF translation, label and artwork preparation, mock-up review, and lifecycle artwork management across regional requirements.
Explore serviceShort answers for teams deciding whether this is the right next step.
Ask us anythingTalk with PharmaRevix about scope, timelines, and the cleanest next step for your market or safety obligation.